Study guide

7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome

BONENT Certified Hemodialysis Nurse CHN

Track your progress as you read

Finished sections get a check mark.

1 Exam Orientation

1.1 Current CHN Exam Facts and Study Strategy

2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology

2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD

3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations

3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management

4 Individualized Nursing Care

4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral

5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry

5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR

6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters

6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention

7 Chapter 5: Cannulation Practice & Access Complications

7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management

8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring

8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment

9 Equipment and Laboratory Skills

9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results

10 Chapter 7: Acute Intradialytic Complications & Emergencies

10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss

11 Extended and Acute Treatment

11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation

12 Chapter 8: Nephrology Pharmacology in Hemodialysis

12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing

13 Home and Peritoneal Dialysis

13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care

14 Kidney Transplantation

14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes

15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing

15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety

16 Clinical Unit Management

16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care

17 Chapter 10: Supervision, Administration & Professional Practice

17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care

18 Professional Development

18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation

19 Environmental Hazards and Emergency Planning

19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions

7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome

Key Takeaways Explain This Topic AI

Neointimal hyperplasia contributes to stenosis at access-specific vulnerable sites.

New abnormal bruit/thrill, prolonged bleeding, swelling or reduced delivered flow warrants access evaluation.

Access-associated pain, coldness, sensory loss or weakness requires prompt assessment for ischemia or neuropathy.

Absent thrill or bruit may indicate thrombosis; seek urgent assessment rather than waiting for a fixed rescue deadline.

Last updated: October 2026

Vascular Access Stenosis, Thrombosis & Steal Syndrome

Vascular access dysfunction is the leading cause of hospitalization and secondary morbidity among patients undergoing maintenance hemodialysis. Anatomical stenosis, catastrophic access thrombosis, and severe extremity ischemia represent major hemodynamic complications that compromise dialytic adequacy and threaten limb viability. A comprehensive understanding of the cellular biology of intimal hyperplasia, physical surveillance findings, ischemic steal pathophysiology, and endovascular salvage protocols allows the certified hemodialysis nurse to intervene promptly to prevent irreversible access loss.

Pathophysiology of Venous Neointimal Hyperplasia (VNIH)

Venous Neointimal Hyperplasia (VNIH) is the underlying pathological hallmark that contributes substantially to stenosis in native fistulas and synthetic grafts. Its significance varies with access anatomy and other lesions.

Under baseline physiological conditions, peripheral veins are low-pressure, low-velocity, high-capacitance conduits exposed to laminar shear stress of approximately 1 to 5 dynes/cm 2 1\text{ to }5\text{ dynes/cm}^2 1 to 5 dynes/cm 2 . Surgical creation of an arteriovenous access abruptly exposes the venous outflow bed to pulsatile arterial pressures, turbulent high-velocity blood flow, and shear stresses exceeding 30 to 100 dynes/cm 2 30\text{ to }100\text{ dynes/cm}^2 30 to 100 dynes/cm 2 . This severe hemodynamic mismatch, compounded by surgical mobilization trauma and disruption of the adventitial vasa vasorum (causing local mural hypoxia), initiates a complex cellular repair cascade:

Endothelial Activation & Cytokine Signaling : Injured and dysfunctional endothelial cells upregulate adhesion molecules and secrete mitogenic cytokines, prominently platelet-derived growth factor (PDGF) , transforming growth factor-beta (TGF-beta) , fibroblast growth factor (bFGF) , and vascular endothelial growth factor (VEGF) .

Myofibroblast & Smooth Muscle Migration : Quiescent vascular smooth muscle cells in the tunica media and adventitial fibroblasts undergo phenotypic switching into proliferative synthetic myofibroblasts. These cells migrate across the internal elastic lamina into the subendothelial tunica intima.

Extracellular Matrix Deposition : Proliferating myofibroblasts synthesize massive quantities of extracellular matrix—primarily fibrillar collagen, fibronectin, and proteoglycans. This uninhibited intimal expansion thickens the vessel wall inward, progressively narrowing the vascular lumen and causing progressive anatomical stenosis.

Anatomical Locations & Clinical Surveillance of Stenosis

VNIH develops at predictable anatomical transition zones where fluid shear stress and turbulence are maximal:

1. Juxta-Anastomotic Stenosis in AVFs

In native AVFs, stenosis most commonly arises within the first 2 to 3 cm immediately downstream from the surgical arteriovenous anastomosis —the swing segment. During surgical construction, this venous segment is mobilized, divided, angulated, and sutured to the feeding artery. The sharp mechanical angle, combined with high-velocity jet flow exiting the arterial anastomosis, creates severe flow separation and localized intimal hyperplasia. Juxta-anastomotic stenosis is the leading cause of early fistula maturation failure and inadequate arterial inflow.

2. Venous Graft-Vein Anastomosis in AVGs

In synthetic AVGs, the venous graft-vein anastomosis is a common site of stenosis. A profound mechanical compliance mismatch exists between the rigid synthetic polytetrafluoroethylene (ePTFE) graft material and the elastic native vein. As pulsatile blood exits the rigid graft into the compliant vein, severe boundary-layer separation, flow recirculation, and low oscillatory shear stress develop on the floor and heel of the venous anastomosis, stimulating aggressive VNIH.

3. Central Vein Stenosis (CVS)

Central vein stenosis involves major venous outflow pathways, including brachiocephalic veins and the superior vena cava. Prior catheter placement can injure central venous endothelium and promote scarring; pacemaker leads and other factors also contribute. Avoid subclavian catheter placement when a suitable alternative exists because it can compromise future access. It is not an absolute prohibition that replaces individualized emergency access decisions.

Clinical Manifestations of Central Vein Stenosis :

When an ipsilateral arteriovenous access is created downstream of a central venous stenosis, high-volume flow encounters massive outflow resistance. Blood cannot drain into the right atrium and is diverted through high-resistance collateral pathways. The patient develops:

Marked, non-pitting edema of the entire ipsilateral extremity, breast, shoulder, neck, and face.

Prominent, tortuous, engorged subcutaneous collateral veins branching across the anterior chest wall and shoulder.

Severely elevated dynamic and intra-access venous pressures during dialysis.

Prolonged bleeding from cannulation puncture sites exceeding 20 to 30 minutes following needle withdrawal.

Physical Examination: Pulse, Thrill, Bruit & Arm Elevation

Palpation : Stenosis causes a hyperpulsatile, pounding "water-hammer" pulse immediately upstream of the lesion, reflecting high downstream outflow resistance. Downstream of the stenosis, the thrill is diminished or absent.

Auscultation : A normal access demonstrates a soft, continuous, low-pitched systolic-diastolic bruit. Over a stenotic lesion, turbulence transforms the bruit into a high-pitched, harsh, discontinuous systolic-only whistling or screeching sound .

Arm Elevation Test : When an extremity with a healthy native AVF is raised above the level of the heart, the access vein completely collapses as gravity assists venous drainage. If a significant venous outflow stenosis is present, blood remains trapped, and the access vein remains distended, turgid, and firm upon elevation ( positive arm elevation test ).

Dialysis Access Steal Syndrome (DASS) & Ischemic Monomelic Neuropathy

Dialysis Access Steal Syndrome (DASS) is a hemodynamic complication wherein arterial blood flow is preferentially shunted away from the distal vascular bed into the low-resistance arteriovenous conduit, causing hypoperfusion and ischemia of the distal extremity.

Pathophysiological Staging & Clinical Manifestations

While physiological "steal" (retrograde arterial flow in the native artery distal to the access) can occur without symptoms, clinical DASS occurs when compensatory collateral vasodilation fails to preserve distal tissue perfusion. DASS is graded clinically:

Grade 1 (Mild) : Coldness of the hand, mild pallor, with minimal or no resting symptoms.

Grade 2 (Moderate) : Ischemic pain, numbness, and paresthesias occurring selectively during hemodialysis sessions. As the extracorporeal blood pump pulls 350 – 450 mL/min 350–450\text{ mL/min} 350–450 mL/min from the inflow artery, distal perfusion pressure drops precipitously, exacerbating limb ischemia.

Grade 3 (Severe) : Unremitting resting ischemic pain, marked digital sensory loss, cyanosis, muscle weakness, and absent radial pulse.

Grade 4 (End-Stage) : Tissue necrosis, non-healing ischemic digital ulcers, and wet or dry gangrene.

Ischemic Monomelic Neuropathy (IMN): A Neurological Emergency

Ischemic Monomelic Neuropathy (IMN) is a devastating, acute neuro-ischemic syndrome that develops within hours of access creation, most commonly in diabetic patients with severe peripheral vascular disease receiving a brachial artery-based fistula. Unlike classic DASS, IMN involves acute, severe, irreversible ischemic axonal injury to multiple peripheral nerves (radial, median, ulnar) without gross muscular or cutaneous necrosis. Patients present with severe, agonizing burning pain in the hand, profound motor paralysis (e.g., wrist drop or claw hand), and global glove distribution sensory loss.

Caution

Emergency IMN Alert: Suspected IMN requires immediate vascular-surgical assessment. Urgent access ligation may be necessary to protect nerve perfusion; delay can lead to permanent disability, and prompt intervention does not guarantee complete recovery.

Diagnostic Evaluation & Surgical Corrections

Diagnostic Confirmation :

Digital-Brachial Index (DBI) : Measured via photoplethysmography. A normal DBI is > 0.8 > 0.8 > 0.8 . A DBI < 0.6 \text{DBI} < 0.6 DBI < 0.6 establishes hemodynamically significant digital hypoperfusion.

Access Occlusion / Pulse Oximetry Test : Placing a pulse oximeter probe on the affected digit demonstrates a flattened waveform and low S p O 2 SpO_2 Sp O 2 ​ . When the nurse or surgeon manually compresses and occludes the access fistula, arterial blood is redirected distally: immediate reappearance of a normal plethysmographic pulse wave and improvement of the waveform supports an access-related perfusion problem. This supervised maneuver and pulse oximetry supplement, rather than replace, vascular assessment; they are not standalone proof of the cause.

Surgical Revascularization Interventions :

DRIL Procedure (Distal Revascularization Interval Ligation) : The definitive surgical standard of care for severe DASS. The feeding native artery is surgically ligated just distal to the arteriovenous anastomosis to eliminate retrograde steal. An autogenous vein bypass graft is constructed from the native artery proximal to the fistula down to the distal native artery beyond the ligation, re-establishing robust antegrade distal limb perfusion while maintaining access patency.

PAI (Proximalization of Arterial Inflow) : Moving the access inflow origin more proximally (e.g., to the axillary artery) to tap into a larger vascular conduit with higher flow capacity.

Banding / RUDI (Revision Using Distal Inflow) : Flow-reducing surgical banding or distal inflow translocation to increase internal vascular resistance and decrease excessive access flow ( Q a Q_a Q a ​ ).

Access Ligation : Emergent closure reserved for refractory gangrene, severe tissue loss, or IMN.

Access Thrombosis: Triggers & Emergency Rescue

Access thrombosis represents the ultimate acute failure of vascular access, resulting in complete cessation of blood flow.

Clinical Presentation & Precipitating Triggers

Thrombosis presents with sudden loss of palpable thrill and audible bruit, a firm, non-compressible, rope-like clot on palpation, and the complete inability to aspirate blood or cannulate the vessel.

Hemodynamic Triggers : Severe intradialytic hypotension (IDH) or post-dialysis hypovolemia. When systemic mean arterial pressure drops, access perfusion pressure falls below the vessel's critical closing pressure, precipitating blood stasis and hypercoagulable thrombosis.

Mechanical Extrinsic Compression : Excessive, prolonged manual pressure or the improper use of rigid mechanical clamps post-dialysis. Hemodialysis puncture sites should never be compressed longer than necessary (typically 10–15 minutes) or clamped with occlusive force that abolishes the vascular thrill.

Underlying Anatomical Stenosis : Stenosis commonly contributes to thrombosis by reducing effective flow. Low-flow findings are interpreted with the technique, access type, clinical indicators and trend; no single screening threshold proves impending thrombosis.

Urgent Interventional Assessment and Salvage

Report suspected thrombosis immediately for urgent access-team evaluation; there is no justification to wait until a fixed 48-hour deadline.

Pharmacomechanical Thrombolysis : A multi-sidehole infusion catheter is embedded into the clot, and pulse-spray fibrinolytic therapy (e.g., recombinant tissue plasminogen activator, tPA ) is injected alongside mechanical fragmentation (e.g., rheolytic thrombectomy or Fogarty balloon maceration).

Treat the underlying lesion: The specialist evaluates causative stenosis and chooses an appropriate endovascular or surgical strategy. Declotting without addressing a clinically important lesion risks recurrent failure; angioplasty is not compulsory for every anatomical finding.

Do not wait for a 24- or 48-hour deadline before reporting an absent thrill: seek urgent access-team evaluation and arrange an alternate dialysis plan if needed. Limb ischemia depends on distal perfusion and vascular disease; the dialysis circuit returns blood rather than simply stealing its whole pump flow from the limb. Ultrafiltration-related hypotension can worsen ischemia. A digital-brachial index supports assessment but is not a standalone diagnosis. Acute pain, weakness or sensory loss after creation may indicate ischemic monomelic neuropathy and needs immediate vascular assessment; prompt intervention does not guarantee full neurologic recovery.

Sources checked 2026-10-10: KDOQI 2019 vascular access